US$ 29.11
foods glp 1 3 that increase GLP-1 π§ Weight loss, blood sugar
Description
It is important to emphasise that GLP-1 receptor agonists should not replace statins as first-line therapy for hypercholesterolaemia
Some patients may need concurrent statin therapy
GLP-1-RAs may enhance glycemic control, weight reduction, and cardiovascular risk, thereby preventing or delaying expensive and severe illnesses, such as CVD, renal disease, and neuropathy

Le KDR, Le K, Foo F

Key results (Phase 3): In a 68-week Phase 3a trial published in The New England Journal of Medicine , cagrilintidesemaglutide (CagriSema) produced large mean weight loss (reported as ~22.7% at 68 weeks in the main efficacy analysis)
Heres a preview of whats driving the buzz: Surging demand for the oral version of Wegovy from Novo Nordisk, with more than half of polled US physicians already prescribing it
